Gene · 7079
Papers1,944
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,944
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autocrine Activity of Extracellular Vesicles Induced by Icariin and Its Effectiveness in Glucocorticoid-Induced Injury of Bone Microvascular Endothelial Cells. | Cells | 2022 | 35741052 | PubTator, text mining | PubMed |
| DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand? | Cancers (Basel) | 2022 | 35740584 | PubTator, text mining | PubMed |
| Effects of ACTH-Induced Long-Term Hypercortisolism on the Transcriptome of Canine Visceral Adipose Tissue. | Vet Sci | 2022 | 35737302 | PubTator, text mining | PubMed |
| Nanotechnology and Matrix Metalloproteinases in Cancer Diagnosis and Treatment. | Front Mol Biosci | 2022 | 35720130 | PubTator, text mining | PubMed |
| Lysyl Oxidase Family Enzymes and Their Role in Tumor Progression. | Int J Mol Sci | 2022 | 35682926 | PubTator, text mining | PubMed |
| Multiwalled Carbon Nanotubes Induce Fibrosis and Telomere Length Alterations. | Int J Mol Sci | 2022 | 35682685 | PubTator, text mining | PubMed |
| Targeted proteomics of appendicular skeletal muscle mass and handgrip strength in black South Africans: a cross-sectional study. | Sci Rep | 2022 | 35680977 | PubTator, text mining | PubMed |
| DNA methylation in pulmonary fibrosis and lung cancer. | Expert Rev Respir Med | 2022 | 35673969 | PubTator, text mining | PubMed |
| Remodeling Factors, Transcription Factors and Angiogenetic Factors in Cholesteatoma in Ontogenetic Aspect. | Iran J Otorhinolaryngol | 2022 | 35655767 | PubTator, text mining | PubMed |
| Genetically regulated gene expression and proteins revealed discordant effects. | PLoS One | 2022 | 35604899 | PubTator, text mining | PubMed |
| Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target. | Front Cardiovasc Med | 2022 | 35600469 | PubTator, text mining | PubMed |
| Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction. | Sci Rep | 2022 | 35595781 | PubTator, text mining | PubMed |
| The potential role of protease systems in hemophilic arthropathy. | Blood Adv | 2022 | 35580335 | PubTator, text mining | PubMed |
| A Disintegrin and Metalloproteinase (ADAM) Family-Novel Biomarkers of Selected Gastrointestinal (GI) Malignancies? | Cancers (Basel) | 2022 | 35565436 | PubTator, text mining | PubMed |
| Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction. | Cells | 2022 | 35563692 | PubTator, text mining | PubMed |
| Anti-POSTN and Anti-TIMP1 Autoantibodies as Diagnostic Markers in Esophageal Squamous Cell Carcinoma. | Front Genet | 2022 | 35559040 | PubTator, text mining | PubMed |
| Circulating 1,3-Beta-D-Glucan is Associated with Lung Function, Respiratory Symptoms, and Mediators of Matrix Degradation in Chronic Obstructive Pulmonary Disease. | Chronic Obstr Pulm Dis | 2022 | 35550241 | PubTator, text mining | PubMed |
| Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers. | BMC Cancer | 2022 | 35545767 | PubTator, text mining | PubMed |
| Disintegrin and Metalloproteinases (ADAMs [A Disintegrin and Metalloproteinase] and ADAMTSs [ADAMs With a Thrombospondin Motif]) in Aortic Aneurysm. | Hypertension | 2022 | 35543145 | PubTator, text mining | PubMed |
| Melanoma cells with diverse invasive potential differentially induce the activation of normal human fibroblasts. | Cell Commun Signal | 2022 | 35538545 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7079/papers?page=18